TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 89 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2014. The put-call ratio across all filers is 8.57 and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $324,000 | +0.3% | 2,878 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $323,000 | -27.3% | 2,878 | -24.4% | 0.00% | -50.0% |
| Q1 2017 | $444,000 | -7.1% | 3,808 | -16.1% | 0.00% | 0.0% |
| Q4 2016 | $478,000 | -70.3% | 4,538 | -68.8% | 0.00% | -71.4% |
| Q3 2016 | $1,607,000 | -24.1% | 14,538 | 0.0% | 0.01% | -22.2% |
| Q2 2016 | $2,117,000 | +491.3% | 14,538 | +481.1% | 0.01% | +350.0% |
| Q1 2016 | $358,000 | +59.1% | 2,502 | +71.8% | 0.00% | +100.0% |
| Q4 2015 | $225,000 | +1507.1% | 1,456 | +1356.0% | 0.00% | – |
| Q3 2015 | $14,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2015 | $14,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2015 | $14,000 | -6.7% | 100 | 0.0% | 0.00% | – |
| Q4 2014 | $15,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q3 2014 | $15,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL LP | 1,104,068 | $104,886,000 | 77.66% |
| Greywolf Capital Management LP | 472,135 | $46,694,000 | 10.17% |
| Consonance Capital Management LP | 263,732 | $26,083,000 | 4.28% |
| Moab Capital Partners | 83,132 | $8,222,000 | 3.77% |
| Raging Capital Management, LLC | 190,151 | $18,806,000 | 3.45% |
| Valentine Capital Asset Management, Inc. | 145,053 | $14,346,000 | 3.07% |
| Assured Investment Management LLC | 1,353,342 | $133,846,000 | 1.21% |
| Ativo Capital Management LLC | 22,828 | $2,258,000 | 0.99% |
| Perceptive Advisors | 56,602 | $5,598,000 | 0.67% |
| Jaffetilchin Investment Partners, LLC | 7,721 | $764,000 | 0.38% |